Concepedia
Statistics
Publications
20
Citations
1.8K
H-Index
17
Active since
2000
Affiliations
Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)
National Jewish Health
University of Colorado Denver
Westchester Medical Center
St. Luke's Hospital
Paul Stryszak is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, allergy, and virology.
Top concepts
MedicineAllergyVirologyHepatitisViral HepatitisAsthmaImmunologyInflammationInfection ControlHepatology
Publications per year
2000–2019
Safety and efficacy of a <scp>CXCR</scp>2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo‐controlled clinical trial
Parameswaran Nair, Mina Gaga, Khuder Alagha et al. · Clinical & Experimental Allergy · 2012 · 328 citations
CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease
Stephen I. Rennard, David C. Dale, James F. Donohue et al. · American Journal of Respiratory and Critical Care Medicine · 2015 · 251 citations
SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects
Olaf Holz, Sauzanne Khalilieh, Andrea Ludwig-Sengpiel et al. · European Respiratory Journal · 2009 · 182 citations · Full text
Acute Lung Injury, Inflammatory Lung Disease, Healthy Subjects +20
Effectiveness of Elbasvir and Grazoprevir Combination, With or Without Ribavirin, for Treatment-Experienced Patients With Chronic Hepatitis C Infection
Paul Y. Kwo, Edward Gane, Cheng‐Yuan Peng et al. · Gastroenterology · 2016 · 173 citations · Full text
Hepatology, Hepatitis C, Viral Hepatitis +9
Efficacy and safety of mometasone furoate nasal spray in nasal polyposis
Catherine B. Small, Eric Schenkel, A Damiano et al. · Journal of Allergy and Clinical Immunology · 2005 · 154 citations
Nasal Polyposis, Allergy, Allergic Rhinitis
1–5 of 20